The regulation of KSHV lytic reactivation is predominantly controlled by the immediate early transactivators of the beta and gamma genes. These genes are responsible for replication of the viral genome and synthesis of the viral core proteins for production of viral progeny. Recently, it has been shown that the latency associated nuclear antigen (LANA) can modulate and shut down the expression of Rta by repressing the activation mediated by cellular factors that bind to cis acting elements as well as the autoactivation by Rta of its own promoter. This study investigates the role of LANA in maintenance of KSHV reactivation control and the requirement for post-translational modification of Rta and LANA for a functional role in this controlled feedback loop. The association with cellular proteins including the association with the transcriptional represser RBP-Jk and HDACs will be further investigated. We will also identify the cellular and viral proteins involved in regulation of this reactivation control which is associated with Rta and LANA using a number of biochemical and proteomics approaches. We will also determine the coactivators and corepressors involved in this regulatory loop which controls the expression of Rta and LANA in the context of KSHV infection and the regulation of the KSHV lytic cycle by using the upstream activator of RBP-Jk for activation of the immediate early promoter if expressed from a heterologous expression system. We will also use strategies for targeted downregulation of Rta to determine if KSHV reactivation can be bypassed in the absence of Rta expression.

National Institute of Health (NIH)
National Institute of Dental & Craniofacial Research (NIDCR)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDE1-YL (13))
Program Officer
Rodriguez-Chavez, Isaac R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Schools of Medicine
United States
Zip Code
Gan, Jin; Wang, Chong; Jin, Yanling et al. (2015) Proteomic profiling identifies the SIM-associated complex of KSHV-encoded LANA. Proteomics 15:2023-37
Dzeng, Richard K; Jha, Hem Chandra; Lu, Jie et al. (2015) Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells. Mol Oncol 9:365-76
Zhang, Liming; Zhu, Caixia; Guo, Yi et al. (2014) Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-J?. J Virol 88:6873-84
Cai, Qiliang; Banerjee, Shuvomoy; Cervini, Amanda et al. (2013) IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation. PLoS Pathog 9:e1003751
Jha, Hem Chandra; Upadhyay, Santosh Kumar; A J Prasad, Mahadesh et al. (2013) H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence. J Virol 87:5255-69
Cai, Qiliang; Cai, Shen; Zhu, Caixia et al. (2013) A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. PLoS Pathog 9:e1003750
Cai, Qiliang; Xiao, Bingyi; Si, Huaxin et al. (2012) Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation. PLoS Pathog 8:e1002566
Lu, Jie; Verma, Subhash C; Cai, Qiliang et al. (2012) The RBP-J? binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation. PLoS Pathog 8:e1002479
Lu, Jie; Verma, Subhash C; Cai, Qiliang et al. (2011) The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection. J Virol 85:6148-61
Lu, Jie; Murakami, Masanao; Verma, Subhash C et al. (2011) Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 410:64-75

Showing the most recent 10 out of 28 publications